A detailed history of Grey Street Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grey Street Capital, LLC holds 16,771 shares of BMY stock, worth $961,481. This represents 0.12% of its overall portfolio holdings.

Number of Shares
16,771
Previous 5,026 233.68%
Holding current value
$961,481
Previous $258 Million 252.67%
% of portfolio
0.12%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$47.98 - $54.4 $563,525 - $638,928
11,745 Added 233.68%
16,771 $909 Million
Q4 2023

Jan 11, 2024

BUY
$48.48 - $57.85 $3,393 - $4,049
70 Added 1.41%
5,026 $258 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $2,199 - $2,459
38 Added 0.77%
4,956 $288 Million
Q2 2023

Jul 13, 2023

BUY
$63.71 - $70.74 $313,325 - $347,899
4,918 New
4,918 $315 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.